Pritha Bhadra

An Observational Study to Evaluate the Risk Factors and Quality of Life in Individuals With Spinal Cord Injury and Pressure Injuries

Pritha Bhadra, Swapnil Sonune, Virendra Kumar Verma, John Ashutosh Santoshi et autres

Background Spinal cord injury (SCI) is a debilitating condition often associated with many complications, of which pressure injury (PI) is one of the most prevalent. Individuals with SCI are at an increased risk of developing PIs due to impaired protective sensations, dependence …

in (code pays fourni par la source)

THE EFFECT OF A MODIFIED TENODESIS WRIST-HAND ORTHOSIS ON HAND FUNCTION IN PATIENTS WITH TETRAPLEGIA

Swapnil P. Sonune, Smita Pathak, Pritha Bhadra, Gaurav Goel

BACKGROUND: An individual experiencing tetraplegia faces functional limitations due to impaired hand function. The use of an affordable tenodesis wrist-hand orthosis (WHO) can enable finger flexion with active wrist extension, thereby enhancing the three-jaw chuck grasp and overall hand functionality. OBJECTIVES: To …

in (code pays fourni par la source)

Pregabalin improves fibromyalgia related sleep disturbance

Malca Resnick, Pritha Bhadra, Verne Pitman, Thomas Röth

us (code pays fourni par la source)

Efficacy and Tolerability of Celecoxib versus Naproxen in Patients with Osteoarthritis of the Knee: A Randomized, Double-Blind, Double-Dummy Trial

Mn Essex, Pritha Bhadra, G. G. Sands

OBJECTIVE: To assess the efficacy and tolerability of celecoxib versus naproxen in patients with osteoarthritis (OA) of the knee. METHODS: This 6-month, randomized, double-blind, double-dummy trial was conducted at 47 centres in the USA. Patients with OA of the knee were randomized …

us (code pays fourni par la source)

AB0967 The effect of body mass on the number of osteoarthritis (OA) flares with continuous vs intermittent celecoxib treatment

Gina Sands, Pritha Bhadra, Margaret Noyes Essex

us (code pays fourni par la source)

AB0968 The efficacy of continuous vs intermittent celecoxib treatment in osteoarthritis (OA) patients with body mass index ≥30 and < 30 kg/m2

Gina Sands, Pritha Bhadra, Margaret Noyes Essex

us (code pays fourni par la source)

Objective and subjective benefits of pregabalin on measures of sleep efficiency in patients with fibromyalgia and sleep maintenance disturbance

Malca Resnick, Thomas Röth, D. Alan Lankford, Pritha Bhadra et autres

us (code pays fourni par la source)

Neurological symptoms in fibromyalgia patients and their relationship to pregabalin efficacy: pooled analysis of phase 3 clinical trials

Danielle Petersel, Pritha Bhadra

us (code pays fourni par la source)

The Effectiveness of a Weak Opioid Medication versus a Cyclo-Oxygenase-2 (COX-2) Selective Non-Steroidal Anti-Inflammatory Drug in Treating Flare-Up of Chronic Low-Back Pain: Results from Two Randomized, Double-Blind, 6-Week Studies

J. O'Donnell, E. Ekman, WM Spalding, Pritha Bhadra et autres

Two 6-week studies compared the analgesic efficacy, tolerability and safety of a non-steroidal anti-inflammatory drug (celecoxib 200 mg twice a day [bid]) and an opioid (tramadol HCl 50 mg four times a day [qid]) in subjects with chronic low-back pain (CLBP). Successful …

us (code pays fourni par la source)

Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy

Jay L. Goldstein, Glenn M. Eisen, B. S. Lewis, Ian M. Gralnek et autres

BACKGROUND: Small bowel mucosal injury associated with non-selective non-steroidal anti-inflammatory drugs is being increasingly recognized. AIM: To evaluate the incidence of small bowel injury in healthy subjects receiving celecoxib or ibuprofen plus omeprazole using video capsule endoscopy (VCE). METHODS: Subjects with normal …

us, il (code pays fourni par la source)

EFFICACY OF CELECOXIB IN KNEE OSTEOARTHRITIS UNRESPONSIVE TO NAPROXEN AND IBUPROFEN

Sally A. Mulhern, Abraham Sunshine, S Songcharoen, Pritha Bhadra et autres

s: XIVth Congress of the Pan-American League of Associations for Rheumatology: CATEGORY: OA: Treatment

ch, us (code pays fourni par la source)